Journal home
Advance online publication
Current issue
Archive
Press releases
Free Association (blog)
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Biotechnology
Nature Cell Biology
Nature Medicine
Nature Methods
Nature Reviews Cancer
Nature Reviews Genetics
Nature Reviews Molecular Cell Biology
news@nature.com
Nature Conferences
RNAi Gateway
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Genetics  4, 72 - 76 (1993)
doi:10.1038/ng0593-72

Origin of the expansion mutation in myotonic dystrophy

Georges Imbert1, Christine Kretz1, Keith Johnson2 & Jean-Louis Mandel1

  1Laboratoire de Génétique Moléculaire des Eucaryotes du CNRS, Unité 184 de l'INSERM, Faculté de Médecine et CHRU, 11 rue Humann, 67085 Strasbourg Cedex, France

  2Department of Anatomy, Charing Cross and Westminster Medical School Fulham Palace Road, London W6 8RF, UK

 Correspondence should be addressed to J-L.M.

Myotonic dystrophy (DM) is caused by the expansion of a CTG trinucleotide repeat. The mutation is in complete linkage disequilibrium with a nearby two−allele insertion/deletion polymorphism, suggesting a single origin for the mutation or predisposing mutation. To trace this ancestral event, we have studied the association of CTG repeat alleles in a normal population to alleles of the insertion/deletion polymorphism and of a (CA)n repeat marker 90 kilobases from the DM mutation. The results strongly suggest that the initial predisposing event(s) consisted of a transition from a (CTG)5 allele to anallele with 19 to 30 repeats. The heterogeneous class of (CTG)19−30 alleles which has an overall frequency of about 10%, may constitute a reservoir for recurrent DM mutations.

REFERENCES
  1. Brook, J.D. et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 68, 799−808 (1992). | Article | PubMed  | ISI | ChemPort |
  2. Fu, Y.-H. et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255, 1256−1258 (1992). | PubMed  | ISI | ChemPort |
  3. Mahadevan, M. et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science 255, 1253−1255 (1992). | PubMed  | ISI | ChemPort |
  4. Yamagata, H. et al. Expansion of unstable DNA region in Japanese myotonic dystrophy patients. Lancet 339, 692 (1992). | Article | PubMed  | ISI | ChemPort |
  5. Harley, H.G. et al. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 355, 545−546 (1992). | Article | PubMed  | ISI | ChemPort |
  6. Fu, Y.-H. et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67, 1047−1058 (1991). | Article | PubMed  | ISI | ChemPort |
  7. Kremer, E.J. et al. Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science 252, 1711−1714 (1991). | PubMed  | ISI | ChemPort |
  8. Oberlé, I. et al. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252, 1097−1102 (1991). | PubMed  | ISI | ChemPort |
  9. Richards, R.I. et al. Evidence of founder chromosomes in fragile X syndrome. Nature Genet. 1, 257−260 (1992). | Article | PubMed  | ISI | ChemPort |
  10. Oudet, C. et al. Linkage disequilibrium between the fragile X mutation and two closely linked CA repeats suggests that fragile X chromosomes are derived from a small number of founder chromosomes. Am. J. hum. Gen. (in the press).
  11. Buxton, J. et al. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 355, 547−548 (1992). | Article | PubMed  | ISI | ChemPort |
  12. Crow, S.R., Harley, H.G., Brook, J.D., Rundle, S.A. & Shaw, D.J. Insertion/deletion polymorphism at D19S95 with the myotonic dystrophy CTG repeat. Hum. molec. Gen. 1, 451 (1992). | ChemPort |
  13. Caskey, C.T., Pizzuti, A., Fu, Y.-H., Fenwick, R.G. & Nelson, D.L. Triplet repeat mutations in human disease. Science 256, 784−789 (1992). | PubMed  | ISI | ChemPort |
  14. Davies, J. et al. Comparison of the myotonic dystrophy associated CTG repeat in European and Japanese populations. J. med. Genet. 29, 766−769 (1992). | PubMed  | ISI | ChemPort |
  15. Brunner, H.G. et al. Presymptomatic diagnosis of myotonic dystrophy. J. med. Genet. 29, 780−784 (1992). | PubMed  | ISI | ChemPort |
  16. Jansen, G. et al. Physical and genetic characterization of the distal segment of the myotonic dystrophy area on 19q. Genomics 13, 509−517 (1992). | PubMed  | ISI | ChemPort |
  17. La Spada, A.R., Wilson, E.M., Lubahn, D.B., Harding, A.E. & Fischbeck, H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352, 77−79 (1991). | Article | PubMed  | ISI | ChemPort |
  18. Biancalana, V. et al. Moderate instability of the trinucleotide repeat in spino bulbar muscular atrophy. Hum. molec. Gen. 1, 255−258 (1992). | ChemPort |
  19. Yu, S. et al. Fragile-X syndrome: unique genetics of the heritable unstable element. Am. J. hum. Genet. 50, 968−980 (1992). | PubMed  | ISI | ChemPort |
  20. Heitz, D., Devys, D., Imbert, G., Kretz, C. & Mandel, J.L. Inheritance of the fragile X syndrome: size of the fragile X premutation is a major determinant of the transition to full mutation. J. med. Genet. 29, 794−801 (1992). | PubMed  | ISI | ChemPort |
  21. Harley, H.G. et al. Unstable DNA sequence in myotonic dystrophy. Lancet 339, 1125−1128 (1992). | Article | PubMed  | ISI | ChemPort |
  22. Shelbourne, P. et al. Unstable DNA may be responsible for the incomplete penetrance of the myotonic dystrophy. Hum. molec Gen. 1, 467−473 (1992). | ChemPort |
  23. Tsifilidis, C., MacKenzie, A.E., Mettler, G., Barcelo, J. & Korneluk, R.G. Correlation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophy. Nature Genet. 1, 192−195 (1992). | PubMed  | ISI | ChemPort |
  24. Edwards, A., Hammond, H.A., Jin, J., Caskey, C.T. & Chakraborty, R. Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics 12, 241−253 (1992). | PubMed  | ISI | ChemPort |
  25. Oudet, C., Heilig, R., Hanauer, A. & Mandel, J.L. Nonradioactive assay for new microsatellite polymorphisms at the 5' end of the dystrophin gene, and estimation of intragenic recombination. Am. J. hum. Genet. 49, 311−319 (1991). | PubMed  | ISI | ChemPort |
  26. Levinson, G. & Gutman, G.A. High frequencies of short frameshifts in poly-CA/TG tandem repeats borne by bacteriophage M13 in Escherichia coli K-12. Nucl. Acids Res. 15, 5323−5338 (1987). | PubMed  | ISI | ChemPort |
  27. Weissenbach, J. et al. A second-generation linkage map of the human genome. Nature 359, 794−801 (1992). | Article | PubMed  | ISI | ChemPort |
  28. Morton, M.E. & MacPherson, J.N. Population genetics of the fragile-X syndrome: muttiallelic model for the FMR1 locus. Proc. natn. Acad. Sci. U.S.A. 89, 4215−4217 (1992). | ChemPort |
  29. Chakravarti, A. Fragile X founder effect? Nature Genet. 1, 237−238 (1992). | Article | PubMed  | ISI | ChemPort |
  30. Weber, J.L. Informativeness of human (dC-dA)n-(dG-dT)n polymorphisms. Genomics 7, 524−530 (1990). | PubMed  | ISI | ChemPort |
  31. Harper, P.S. Myotonic dystrophy and related disorders. In Principles and practice of medical genetics (eds Emery, A.E. H. & Rimoin, D.L.) 579−598 (Churchill Livingstone, Edinburgh, 1990).
  32. La Spada, A.R. et al. Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Nature Genet. 2, 301−304 (1992). | PubMed  | ChemPort |
  33. Rousseau, F. et al. Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. New Engl. J. Med. 325, 1673−1681 (1991). | PubMed  | ISI | ChemPort |
 Top
 Top
Abstract
Previous | Next
Table of contents
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

References
Export citation
Export references
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Genetics
ISSN: 1061-4036
EISSN: 1546-1718
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©1993 Nature Publishing Group | Privacy policy